245 related articles for article (PubMed ID: 20580354)
1. The amyloid fibrils of the constant domain of immunoglobulin light chain.
Yamamoto K; Yagi H; Lee YH; Kardos J; Hagihara Y; Naiki H; Goto Y
FEBS Lett; 2010 Aug; 584(15):3348-53. PubMed ID: 20580354
[TBL] [Abstract][Full Text] [Related]
2. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH.
Ookoshi T; Hasegawa K; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H
Nephrol Dial Transplant; 2008 Oct; 23(10):3247-55. PubMed ID: 18467373
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
[TBL] [Abstract][Full Text] [Related]
4. Role of conformational change in the C-terminus of beta2-microglobulin in dialysis-related amyloidosis.
Kim J; Motomiya Y; Ueda M; Nakamura M; Misumi Y; Saito S; Ikemizu S; Misumi S; Ota K; Shinriki S; Kai H; Ando Y
Ann Clin Biochem; 2008 Sep; 45(Pt 5):489-95. PubMed ID: 18753422
[TBL] [Abstract][Full Text] [Related]
5. Growth of beta(2)-microglobulin-related amyloid fibrils by non-esterified fatty acids at a neutral pH.
Hasegawa K; Tsutsumi-Yasuhara S; Ookoshi T; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H
Biochem J; 2008 Dec; 416(2):307-15. PubMed ID: 18637792
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation.
Qin Z; Hu D; Zhu M; Fink AL
Biochemistry; 2007 Mar; 46(11):3521-31. PubMed ID: 17315948
[TBL] [Abstract][Full Text] [Related]
7. Fibril protein fragmentation pattern in systemic AL-amyloidosis.
Enqvist S; Sletten K; Westermark P
J Pathol; 2009 Dec; 219(4):473-80. PubMed ID: 19771564
[TBL] [Abstract][Full Text] [Related]
8. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
Bellotti V; Mangione P; Merlini G
J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
[TBL] [Abstract][Full Text] [Related]
9. Thiol compounds inhibit the formation of amyloid fibrils by beta 2-microglobulin at neutral pH.
Yamamoto K; Yagi H; Ozawa D; Sasahara K; Naiki H; Goto Y
J Mol Biol; 2008 Feb; 376(1):258-68. PubMed ID: 18155723
[TBL] [Abstract][Full Text] [Related]
10. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding.
Blancas-Mejía LM; Horn TJ; Marin-Argany M; Auton M; Tischer A; Ramirez-Alvarado M
Biophys Chem; 2015 Dec; 207():13-20. PubMed ID: 26263488
[TBL] [Abstract][Full Text] [Related]
12. Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with beta2-microglobulin (beta2-m) and may help initiate beta2-m amyloid fibril formation in connective tissues.
Morimoto H; Wada J; Font B; Mott JD; Hulmes DJ; Ookoshi T; Naiki H; Yasuhara A; Nakatsuka A; Fukuoka K; Takatori Y; Ichikawa H; Akagi S; Nakao K; Makino H
Matrix Biol; 2008 Apr; 27(3):211-9. PubMed ID: 18164932
[TBL] [Abstract][Full Text] [Related]
13. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.
Olsen KE; Sletten K; Westermark P
Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin.
Ohhashi Y; Kihara M; Naiki H; Goto Y
J Biol Chem; 2005 Sep; 280(38):32843-8. PubMed ID: 16046408
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils.
Naiki H; Yamamoto S; Hasegawa K; Yamaguchi I; Goto Y; Gejyo F
Amyloid; 2005 Mar; 12(1):15-25. PubMed ID: 16076607
[TBL] [Abstract][Full Text] [Related]
17. Truncation of the constant domain drives amyloid formation by immunoglobulin light chains.
Lavatelli F; Natalello A; Marchese L; Ami D; Corazza A; Raimondi S; Mimmi MC; Malinverni S; Mangione PP; Palmer MT; Lampis A; Concardi M; Verona G; Canetti D; Arbustini E; Bellotti V; Giorgetti S
J Biol Chem; 2024 Apr; 300(4):107174. PubMed ID: 38499153
[TBL] [Abstract][Full Text] [Related]
18. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
[TBL] [Abstract][Full Text] [Related]
19. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
Harris DL; King E; Ramsland PA; Edmundson AB
J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
[TBL] [Abstract][Full Text] [Related]
20. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
